scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.2010.1042 |
P953 | full work available at URL | https://jamanetwork.com/journals/jama/articlepdf/186300/joc05090_426_434.pdf |
http://jama.ama-assn.org/cgi/content/abstract/304/4/426 | ||
http://jamanetwork.com/journals/jama/fullarticle/186300 | ||
P698 | PubMed publication ID | 20664043 |
P5875 | ResearchGate publication ID | 45388999 |
P50 | author | Richard Peto | Q441534 |
Valerie Beral | Q4793379 | ||
Mark Lathrop | Q6768494 | ||
Diana Zelenika | Q30248012 | ||
Million Women Study Collaborators | Q73545466 | ||
Gillian K Reeves | Q73562500 | ||
Ruth Travis | Q86575888 | ||
Krys Baker | Q90743238 | ||
Sarah J Tipper | Q114783784 | ||
P2093 | author name string | Jane Green | |
John Bell | |||
Diana Bull | |||
Sarah Tipper | |||
Ruth C. Travis | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | single-nucleotide polymorphism | Q501128 |
susceptibility locus | Q62091149 | ||
genetic predisposition to disease | Q64843122 | ||
P304 | page(s) | 426-434 | |
P577 | publication date | 2010-07-01 | |
2010-07-28 | |||
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci | |
Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci | |||
P478 | volume | 304 |
Q61811613 | A TGF-β1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer |
Q45305326 | A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. |
Q33923726 | A conceptual and methodological framework for investigating etiologic heterogeneity |
Q57918178 | A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population |
Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
Q34685625 | A novel multiplex tetra-primer ARMS-PCR for the simultaneous genotyping of six single nucleotide polymorphisms associated with female cancers |
Q34177313 | A pathway-based association analysis model using common and rare variants. |
Q38958555 | A polygenic risk score for breast cancer risk in a Taiwanese population. |
Q30842220 | Approaches to integrating germline and tumor genomic data in cancer research |
Q34970225 | Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies |
Q31139519 | Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies |
Q36870426 | Association between a multi-locus genetic risk score and inflammatory bowel disease |
Q92695460 | Association between rs2188380 and the risk of breast cancer in southwest Chinese population |
Q54328968 | Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of northeast China. |
Q40829395 | Associations of Genetic Variants at Nongenic Susceptibility Loci with Breast Cancer Risk and Heterogeneity by Tumor Subtype in Southern Han Chinese Women. |
Q54284105 | Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status. |
Q36393157 | Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women |
Q34577224 | Breast cancer risk in relation to the interval between menopause and starting hormone therapy |
Q28397311 | Breast cancer subtypes and previously established genetic risk factors: a bayesian approach |
Q89008777 | Cohort Profile: the Million Women Study |
Q35682030 | Combined effect of low-penetrant SNPs on breast cancer risk. |
Q37690575 | Common breast cancer risk variants in the post-COGS era: a comprehensive review |
Q35889575 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. |
Q53284479 | Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. |
Q50511174 | Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer. |
Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
Q36489228 | Detecting and exploiting etiologic heterogeneity in epidemiologic studies |
Q40581457 | Evaluation of a Novel Difficulty of Smoking Cessation Phenotype Based on Number of Quit Attempts |
Q64912700 | Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. |
Q44643445 | Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer |
Q41040904 | Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study |
Q37735955 | Genetic Predisposition of Polymorphisms in HMGB1-Related Genes to Breast Cancer Prognosis in Korean Women |
Q35806601 | Genetic risk variants associated with in situ breast cancer |
Q36514074 | Genetic susceptibility loci for subtypes of breast cancer in an African American population |
Q36839582 | Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer |
Q33814873 | Genetic-epigenetic interactions in cis: a major focus in the post-GWAS era |
Q57418753 | Genome-wide association study of cognitive flexibility assessed by the Wisconsin Card Sorting Test |
Q37371491 | Hormone-related pathways and risk of breast cancer subtypes in African American women |
Q36166473 | How genes influence life span: the biodemography of human survival |
Q40591033 | Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population |
Q36051807 | Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer |
Q37961088 | Integrative genomics strategies to elucidate the complexity of drug response |
Q35166701 | Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium |
Q34314805 | Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer |
Q34613569 | Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups |
Q35119701 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium |
Q37631437 | Novel Nine-Exon AR Transcripts (Exon 1/Exon 1b/Exons 2-8) in Normal and Cancerous Breast and Prostate Cells |
Q54687752 | Opposing effects of pro- and anti-inflammatory cytokine gene polymorphisms on the risk for breast cancer in western Indian women: a pilot study. |
Q36024515 | Oxidative balance and colon and rectal cancer: interaction of lifestyle factors and genes |
Q34176996 | Pathway-based joint effects analysis of rare genetic variants using Genetic Analysis Workshop 17 exon sequence data |
Q84177042 | Personal genomic testing as part of the complete breast cancer risk assessment: a case report |
Q38003704 | Pharmacogenetics of aromatase inhibitors. |
Q36381861 | Prediction of Colorectal Cancer Risk Using a Genetic Risk Score: The Korean Cancer Prevention Study-II (KCPS-II). |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q37223335 | Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status |
Q36629530 | Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas |
Q92683687 | Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases |
Q34872387 | Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk |
Q34973472 | Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk |
Q36245573 | Reproductive aging-associated common genetic variants and the risk of breast cancer |
Q37645149 | Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China. |
Q90264934 | Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population |
Q30427359 | Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study |
Q92993050 | Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts |
Q26765220 | TOX gene: a novel target for human cancer gene therapy |
Q37237634 | The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk |
Q33975510 | The associations between immunity-related genes and breast cancer prognosis in Korean women |
Q57131263 | The benefits and harms of breast cancer screening: an independent review |
Q36925187 | The genetics of breast cancer: risk factors for disease |
Q36871650 | The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes |
Q34523801 | The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients |
Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
Search more.